批准日期,申请提交历史,通知信,药品说明书,审评文件等信息
提交状态日期 | 提交号 | 审批结论 | 申请内容分类 | 审评优先级;罕用药状态 | 通知信、审评文件、说明书、包装标签 | 备注 |
2024/08/22 |
SUPPL-28(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2021/07/06 |
SUPPL-24(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2020/04/29 |
SUPPL-21(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2020/04/29 |
SUPPL-19(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2015/02/12 |
SUPPL-15(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2015/02/12 |
SUPPL-13(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2007/10/31 |
SUPPL-2(补充) |
Approval |
Manufacturing (CMC) |
|
|
|
2006/07/25 |
ORIG-1(原始申请) |
Approval |
|
|
|
|
与本品相关的专利信息(来自FDA橙皮书Orange Book)
关联产品号 | 专利号 | 专利过期日 | 是否物质专利 | 是否产品专利 | 专利用途代码 | 撤销请求 | 提交日期 | 专利下载 | 备注 |
无 |
与本品治疗等效的药品
活性成分:AMPICILLIN SODIUM; SULBACTAM SODIUM 剂型/给药途径:INJECTABLE;INJECTION 规格:EQ 1GM BASE/VIAL;EQ 500MG BASE/VIAL 治疗等效代码:AP
申请号 | 产品号 | 申请类型 | 商品名 | 活性成分 | 剂型/给药途径 | 规格 | 市场状态 | RLD | RS | TE Code | 产品号批准日期 | 申请人 |
050608 |
002 |
NDA |
UNASYN |
AMPICILLIN SODIUM; SULBACTAM SODIUM |
INJECTABLE;INJECTION |
EQ 1GM BASE/VIAL;EQ 500MG BASE/VIAL |
Prescription |
Yes |
Yes |
AP |
1986/12/31
|
PFIZER |
062901 |
001 |
ANDA |
UNASYN |
AMPICILLIN SODIUM; SULBACTAM SODIUM |
INJECTABLE;INJECTION |
EQ 1GM BASE/VIAL;EQ 500MG BASE/VIAL |
Discontinued |
No |
No |
AP |
1988/11/23
|
PFIZER |
065074 |
001 |
ANDA |
AMPICILLIN AND SULBACTAM |
AMPICILLIN SODIUM; SULBACTAM SODIUM |
INJECTABLE;INJECTION |
EQ 1GM BASE/VIAL;EQ 500MG BASE/VIAL |
Prescription |
No |
No |
AP |
2002/03/19
|
HIKMA |
065222 |
001 |
ANDA |
AMPICILLIN AND SULBACTAM |
AMPICILLIN SODIUM; SULBACTAM SODIUM |
INJECTABLE;INJECTION |
EQ 1GM BASE/VIAL;EQ 500MG BASE/VIAL |
Prescription |
No |
No |
AP |
2005/11/29
|
ISTITUTO BIO ITA SPA |
065176 |
001 |
ANDA |
AMPICILLIN AND SULBACTAM |
AMPICILLIN SODIUM; SULBACTAM SODIUM |
INJECTABLE;INJECTION |
EQ 1GM BASE/VIAL;EQ 500MG BASE/VIAL |
Prescription |
No |
No |
AP |
2005/11/30
|
HQ SPECLT PHARMA |
065241 |
001 |
ANDA |
AMPICILLIN AND SULBACTAM |
AMPICILLIN SODIUM; SULBACTAM SODIUM |
INJECTABLE;INJECTION |
EQ 1GM BASE/VIAL;EQ 500MG BASE/VIAL |
Prescription |
No |
No |
AP |
2006/07/25
|
SANDOZ |
065310 |
001 |
ANDA |
AMPICILLIN AND SULBACTAM |
AMPICILLIN SODIUM; SULBACTAM SODIUM |
INJECTABLE;INJECTION |
EQ 1GM BASE/VIAL;EQ 500MG BASE/VIAL |
Prescription |
No |
No |
AP |
2006/07/25
|
SANDOZ |
065406 |
001 |
ANDA |
AMPICILLIN AND SULBACTAM |
AMPICILLIN SODIUM; SULBACTAM SODIUM |
INJECTABLE;INJECTION |
EQ 1GM BASE/VIAL;EQ 500MG BASE/VIAL |
Prescription |
No |
No |
AP |
2009/12/22
|
ACS DOBFAR |
090349 |
001 |
ANDA |
AMPICILLIN AND SULBACTAM |
AMPICILLIN SODIUM; SULBACTAM SODIUM |
INJECTABLE;INJECTION |
EQ 1GM BASE/VIAL;EQ 500MG BASE/VIAL |
Prescription |
No |
No |
AP |
2010/09/20
|
EUGIA PHARMA SPECLTS |
201024 |
001 |
ANDA |
AMPICILLIN AND SULBACTAM |
AMPICILLIN SODIUM; SULBACTAM SODIUM |
INJECTABLE;INJECTION |
EQ 1GM BASE/VIAL;EQ 500MG BASE/VIAL |
Prescription |
No |
No |
AP |
2014/04/07
|
STERISCIENCE SPECLTS |
201406 |
001 |
ANDA |
AMPICILLIN AND SULBACTAM |
AMPICILLIN SODIUM; SULBACTAM SODIUM |
INJECTABLE;INJECTION |
EQ 1GM BASE/VIAL;EQ 500MG BASE/VIAL |
Prescription |
No |
No |
AP |
2015/12/07
|
ANTIBIOTICE |
090579 |
001 |
ANDA |
AMPICILLIN AND SULBACTAM |
AMPICILLIN SODIUM; SULBACTAM SODIUM |
INJECTABLE;INJECTION |
EQ 1GM BASE/VIAL;EQ 500MG BASE/VIAL |
Discontinued |
No |
No |
AP |
2016/01/08
|
ASTRAL |
活性成分:AMPICILLIN SODIUM; SULBACTAM SODIUM 剂型/给药途径:INJECTABLE;INJECTION 规格:EQ 2GM BASE/VIAL;EQ 1GM BASE/VIAL 治疗等效代码:AP
申请号 | 产品号 | 申请类型 | 商品名 | 活性成分 | 剂型/给药途径 | 规格 | 市场状态 | RLD | RS | TE Code | 产品号批准日期 | 申请人 |
050608 |
001 |
NDA |
UNASYN |
AMPICILLIN SODIUM; SULBACTAM SODIUM |
INJECTABLE;INJECTION |
EQ 2GM BASE/VIAL;EQ 1GM BASE/VIAL |
Prescription |
Yes |
Yes |
AP |
1986/12/31
|
PFIZER |
062901 |
002 |
ANDA |
UNASYN |
AMPICILLIN SODIUM; SULBACTAM SODIUM |
INJECTABLE;INJECTION |
EQ 2GM BASE/VIAL;EQ 1GM BASE/VIAL |
Discontinued |
No |
No |
AP |
1992/02/27
|
PFIZER |
065074 |
002 |
ANDA |
AMPICILLIN AND SULBACTAM |
AMPICILLIN SODIUM; SULBACTAM SODIUM |
INJECTABLE;INJECTION |
EQ 2GM BASE/VIAL;EQ 1GM BASE/VIAL |
Prescription |
No |
No |
AP |
2002/03/19
|
HIKMA |
065222 |
002 |
ANDA |
AMPICILLIN AND SULBACTAM |
AMPICILLIN SODIUM; SULBACTAM SODIUM |
INJECTABLE;INJECTION |
EQ 2GM BASE/VIAL;EQ 1GM BASE/VIAL |
Prescription |
No |
No |
AP |
2005/11/29
|
ISTITUTO BIO ITA SPA |
065176 |
002 |
ANDA |
AMPICILLIN AND SULBACTAM |
AMPICILLIN SODIUM; SULBACTAM SODIUM |
INJECTABLE;INJECTION |
EQ 2GM BASE/VIAL;EQ 1GM BASE/VIAL |
Prescription |
No |
No |
AP |
2005/11/30
|
HQ SPECLT PHARMA |
065241 |
002 |
ANDA |
AMPICILLIN AND SULBACTAM |
AMPICILLIN SODIUM; SULBACTAM SODIUM |
INJECTABLE;INJECTION |
EQ 2GM BASE/VIAL;EQ 1GM BASE/VIAL |
Prescription |
No |
No |
AP |
2006/07/25
|
SANDOZ |
065310 |
002 |
ANDA |
AMPICILLIN AND SULBACTAM |
AMPICILLIN SODIUM; SULBACTAM SODIUM |
INJECTABLE;INJECTION |
EQ 2GM BASE/VIAL;EQ 1GM BASE/VIAL |
Prescription |
No |
No |
AP |
2006/07/25
|
SANDOZ |
065406 |
002 |
ANDA |
AMPICILLIN AND SULBACTAM |
AMPICILLIN SODIUM; SULBACTAM SODIUM |
INJECTABLE;INJECTION |
EQ 2GM BASE/VIAL;EQ 1GM BASE/VIAL |
Prescription |
No |
No |
AP |
2009/12/22
|
ACS DOBFAR |
090349 |
002 |
ANDA |
AMPICILLIN AND SULBACTAM |
AMPICILLIN SODIUM; SULBACTAM SODIUM |
INJECTABLE;INJECTION |
EQ 2GM BASE/VIAL;EQ 1GM BASE/VIAL |
Prescription |
No |
No |
AP |
2010/09/20
|
EUGIA PHARMA SPECLTS |
201024 |
002 |
ANDA |
AMPICILLIN AND SULBACTAM |
AMPICILLIN SODIUM; SULBACTAM SODIUM |
INJECTABLE;INJECTION |
EQ 2GM BASE/VIAL;EQ 1GM BASE/VIAL |
Prescription |
No |
No |
AP |
2014/04/07
|
STERISCIENCE SPECLTS |
201406 |
002 |
ANDA |
AMPICILLIN AND SULBACTAM |
AMPICILLIN SODIUM; SULBACTAM SODIUM |
INJECTABLE;INJECTION |
EQ 2GM BASE/VIAL;EQ 1GM BASE/VIAL |
Prescription |
No |
No |
AP |
2015/12/07
|
ANTIBIOTICE |
090579 |
002 |
ANDA |
AMPICILLIN AND SULBACTAM |
AMPICILLIN SODIUM; SULBACTAM SODIUM |
INJECTABLE;INJECTION |
EQ 2GM BASE/VIAL;EQ 1GM BASE/VIAL |
Discontinued |
No |
No |
AP |
2016/01/08
|
ASTRAL |